Core Scientific reported a gross margin of 42.66% and a net margin of -703.59% for the quarter ended Jun 2026. These financial ratios cover 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||
| Gross Margin | 51.64% | 46.84% | 36.36% | 7.76% | -16.65% | -38.96% | 26.34% | 29.12% | 13.66% | 27.69% | 43.31% | 27.51% | -0.16% | 5.02% | 10.33% | 6.39% | 4.81% | 26.02% | 26.12% | 42.66% | ||
| EBT Margin | -15.42% | 25.50% | -220.13% | -523.95% | -260.90% | -376.36% | -0.24% | -7.19% | -36.34% | -137.64% | 117.63% | -639.26% | -477.30% | -306.32% | 724.87% | -1,191.23% | -177.43% | 270.87% | -300.74% | -702.43% | ||
| EBIT Margin | 4.23% | 33.85% | -13.88% | -637.54% | -246.89% | -524.60% | 6.30% | 7.46% | -10.67% | 2.77% | 30.80% | -64.27% | -43.23% | -68.89% | -59.15% | -33.43% | -67.56% | -147.28% | -269.36% | -47.79% | ||
| EBITDA Margin | 4.23% | 33.85% | -13.88% | -637.54% | -246.89% | -524.60% | 6.30% | 7.46% | -10.67% | 2.77% | 30.80% | -64.27% | -43.23% | -68.89% | -59.15% | -33.43% | -67.56% | -147.28% | -269.36% | -47.79% | ||
| Operating Margin | 4.23% | 33.85% | -13.88% | -637.54% | -246.89% | -524.60% | 6.30% | 7.46% | -10.67% | 2.77% | 30.80% | -64.27% | -43.23% | -68.89% | -59.15% | -33.43% | -67.56% | -147.28% | -269.36% | -47.79% | ||
| Net Margin | -13.24% | 20.64% | -242.16% | -494.25% | -267.45% | -358.63% | -0.32% | -7.30% | -36.44% | -137.89% | 117.51% | -639.37% | -477.44% | -306.74% | 724.62% | -1,191.43% | -177.59% | 270.74% | -301.26% | -703.59% | ||
| FCF Margin | -107.96% | 74.82% | -71.08% | 24.13% | -35.25% | -19.99% | 15.25% | 14.03% | 2.38% | 7.09% | -5.42% | -1.37% | -26.70% | -15.75% | -162.24% | -111.00% | -138.97% | -152.62% | -120.92% | -355.63% | ||
| Efficiency | ||||||||||||||||||||||
| Assets AverageAssets Avg. | 347.34M | 1,392.97M | 2,571.46M | 2,274.60M | 1,624.58M | 1,105.84M | 783.85M | 755.44M | 728.16M | 708.81M | 763.06M | 739.08M | 744.39M | 1,150.27M | 1,487.00M | 1,674.40M | 2,011.02M | 2,259.47M | 2,708.60M | 4,163.53M | ||
| Invested CapitalInvested Cap. | -35.49M | 2,069.42M | 2,289.38M | 1,486.45M | 1,050.63M | -373.10M | -361.82M | -364.70M | 389.15M | 211.50M | 261.40M | -636.01M | -334.12M | 147.23M | 779.24M | -134.29M | -193.63M | 97.58M | 1,594.66M | 3,690.20M | ||
| Asset Utilization RatioAsset Util. | 0.39 | 0.27 | 0.34 | 0.51 | 0.58 | 0.73 | 0.70 | 0.66 | 0.71 | 0.74 | 0.78 | 0.75 | 0.44 | 0.28 | 0.21 | 0.17 | 0.14 | 0.13 | 0.11 | |||
| Leverage & Solvency | ||||||||||||||||||||||
| Debt Ratio | 0.04 | 0.30 | 0.43 | 0.58 | 0.70 | 0.04 | 0.05 | 0.04 | 1.15 | 1.14 | 0.71 | 0.82 | 0.60 | 0.74 | 0.73 | 0.57 | 0.49 | 0.45 | 0.94 | 1.16 | ||
| Return Ratios | ||||||||||||||||||||||
| Return on Sales [ROS]ROS | 4.23% | 33.85% | -13.88% | -637.54% | -246.89% | -524.60% | 6.30% | 7.46% | -10.67% | 2.77% | 30.80% | -64.27% | -43.23% | -68.89% | -59.15% | -33.43% | -67.56% | -147.28% | -269.36% | -47.79% | ||
| Return on Capital Employed [ROCE]ROCE | 8.54% | 12.26% | 4.44% | -54.90% | -408.65% | -229.54% | -357.55% | -179.62% | -151.88% | 4.07% | 9.05% | -6.56% | -10.89% | -13.99% | -18.92% | -16.19% | -14.43% | -16.62% | -1,087.06% | -39.36% | ||
| Return on Invested Capital [ROIC]ROIC | 9.69% | 5.09% | -51.52% | -109.48% | -617.79% | 545.45% | 277.54% | -4,945.31% | 2.99% | 24.49% | 23.28% | 15.01% | 152.13% | -52.79% | -55.84% | 118.15% | 512.44% | -60.20% | -21.28% | |||
| Return on Assets [ROA]ROA | -3.80% | 3.39% | -16.56% | -54.20% | -101.62% | -194.08% | -214.38% | -116.39% | -66.69% | -34.78% | -4.64% | -125.60% | -180.34% | -125.01% | -72.11% | -66.11% | -39.57% | -12.77% | -44.75% | -34.36% |